Peter C. Farrell
Director at ResMed; Director at Arcturus Therapeutics Holdings; Director at Evolus. Based in San Diego, California.
- Rank
- 7065th of 14,644
- Companies held
- 3
- Largest holding
- RMD, 91.6% of total
- Latest SEC filing
- Nov 11, 2026
What the $13.4M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| ResMed RMD ResMed Common Stock | Directly | 51,634 | $236.88 | $12.2M | 91.6% | Form 4, Nov 11, 2026 |
| Arcturus Therapeutics Holdings ARCT Common Stock | Directly | 55,741 | $7.60 | $424K | 3.2% | Form 4, Jun 14, 2024 |
| Arcturus Therapeutics Holdings ARCT Common Stock | Peter C. Farrell Trust. | 42,955 | $7.60 | $326K | 2.4% | Form 4, Jun 14, 2024 |
| Evolus EOLS Common Stock | Directly | 43,174 | $7.00 | $302K | 2.3% | Form 4, Jan 27, 2023 |
| Evolus EOLS Common Stock | Through trust | 10,000 | $7.00 | $70K | 0.5% | Form 4, Jan 27, 2023 |
Share counts are the amounts Peter C. Farrell reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 2, 2026 | Sold | RMD | 970 | $234.73 | $228K | View |
| Aug 5, 2026 | Sold | RMD | 8,000 | $225.00 | $1.8M | View |
| Apr 1, 2026 | Sold | RMD | 2,000 | $225.00 | $450K | View |
| Mar 4, 2026 | Sold | RMD | 2,000 | $260.22 | $520K | View |
| Feb 4, 2026 | Sold | RMD | 2,000 | $251.31 | $503K | View |
| Jan 7, 2026 | Sold | RMD | 2,000 | $248.83 | $498K | View |
| Dec 3, 2025 | Sold | RMD | 2,000 | $251.47 | $503K | View |
| Nov 12, 2025 | Sold | RMD | 2,000 | $252.05 | $504K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 7062 | Francisco Javier Fernandez-Carbajal Director, Visa. San Francisco, CA | $13.4M |
| 7063 | Adrienne S. Brown EVP, President LLY Imm, Eli Lilly and. Indianapolis, IN | $13.4M |
| 7064 | Robert C. Abernethy Director, Peoples Bancorp of North Carolina. Newton, NC | $13.4M |
| 7065 | Peter C. Farrell Director, ResMed. San Diego, CA | $13.4M |
| 7066 | Michael Scott Sarner President and CEO, Capital Southwest. Dallas, TX | $13.4M |
| 7067 | Shawn M. O.'Connell President and CEO, EnerSys. Reading, PA | $13.3M |
| 7068 | Massimo Andolina Group Chief Financial Officer, Philip Morris International. Stamford, CT | $13.3M |
Other ResMed insiders
All RMD insiders- Robert Douglas$122MSpecial Advisor. #1302 overall
- Michael J. Farrell$112MChairman and CEO. #1381 overall
- David Pendarvis$21.3MChief Administrative Officer. #4700 overall
- Brett Sandercock$19.8MChief Financial Officer. #5248 overall
- James Hollingshead$18.2MPresident, Sleep Business. #4170 overall
- Justin Leong$8.4MChief Product Officer. #10010 overall
Questions
How much stock does Peter C. Farrell own?
Peter C. Farrell holds $13,353,370 in listed stock based on SEC filings and current prices, mostly ResMed (RMD). That ranks 7065th on the Stock Rich List.
Is this Peter C. Farrell's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Peter C. Farrell last buy or sell stock?
The most recent open-market trade on file is a sale of 970 RMD shares on Sep 2, 2026 at $234.73.